Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human mitochondrial complex I dysfunction.

J M Cooper1, V M Mann, D Krige

  • 1Department of Neuroscience, Royal Free Hospital School of Medicine, London, UK.

Biochimica Et Biophysica Acta
|July 17, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creating tissue on chip constructs in microtitre plates for drug discovery.

RSC advances·2022
Same author

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.

Scientific reports·2018
Same author

Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects.

Clinical toxicology (Philadelphia, Pa.)·2016
Same author

Corrigendum: Visualization of Surface Acoustic Waves in Thin Liquid Films.

Scientific reports·2016
Same author

Visualization of Surface Acoustic Waves in Thin Liquid Films.

Scientific reports·2016
Same author

Assessment of biocompatibility of 3D printed photopolymers using zebrafish embryo toxicity assays.

Lab on a chip·2015
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Mitochondrial complex I dysfunction is common in mitochondrial myopathy due to mitochondrial DNA abnormalities. This defect is also increasingly linked to Parkinson's disease, but its exact cause and role in neurodegeneration are still unclear.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Genetics

Background:

  • Complex I (NADH:ubiquinone oxidoreductase) is a crucial enzyme in the mitochondrial electron transport chain.
  • Dysfunction of complex I is a hallmark of various mitochondrial myopathies.
  • Accumulating evidence suggests a role for complex I defects in Parkinson's disease pathogenesis.

Purpose of the Study:

  • To review the evidence linking complex I dysfunction to mitochondrial myopathies and Parkinson's disease.
  • To highlight the susceptibility of complex I to mitochondrial DNA abnormalities.
  • To discuss the unresolved questions regarding the cause and consequences of complex I deficiency in neurodegeneration.

Main Methods:

  • Analysis of patient mitochondria.
  • Review of existing literature on complex I function in disease.

Related Experiment Videos

Main Results:

  • Complex I function and assembly are highly sensitive to mitochondrial DNA mutations (point mutations or deletions) in mitochondrial myopathies.
  • A significant percentage of mitochondrial myopathy patients exhibit complex I dysfunction.
  • Evidence for complex I deficiency in Parkinson's disease is growing.

Conclusions:

  • Mitochondrial DNA abnormalities are a key factor in complex I dysfunction observed in mitochondrial myopathies.
  • The precise mechanisms underlying complex I deficiency in Parkinson's disease and its contribution to dopaminergic cell death require further investigation.